Significant Findings
Significant Findings is MOD's weekly email newsletter for progressive minded, full scope-centric optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes and current events relatable to the practice of optometry, and more—all curated by Josh Davidson, OD, FSLS, FAAO. Subscribe today!
The opinions expressed here are those of the author, Josh Davidson, OD, FSLS, FAAO, and do not necessarily reflect those of Modern Optometry or its publisher, Bryn Mawr Communications.
Josh Davidson, OD, FSLS, FAAO
Financial disclosures: CEO/Co-Founder (Eyedration), Speaker (Allergan/AbbVie, Eyevance Pharmaceuticals/Santen), Researcher (Alcon)
113-128 of 152
- Significant Findings
Ryzumvi Approved to Treat Pharmacologically Induced Mydriasis
Josh Davidson, OD, FSLS, FAAOJosh Davidson, OD, FSLS, FAAO - Significant Findings
An Attempt to Provide Veterans With Greater Access to Care
Josh Davidson, OD, FSLS, FAAOJosh Davidson, OD, FSLS, FAAO - Significant Findings
Patients With Certain Lipids May Be at High Risk of Developing POAG
Josh Davidson, OD, FSLS, FAAOJosh Davidson, OD, FSLS, FAAO - Significant Findings
Encourage Patients With DED to Examine Their Sleep Quality
Josh Davidson, OD, FSLS, FAAOJosh Davidson, OD, FSLS, FAAO - Significant Findings
Prevalence of Keratoconus is 10x Higher Than Previously Thought
Josh Davidson, OD, FSLS, FAAOJosh Davidson, OD, FSLS, FAAO - Significant Findings
Antioxidant Molecule Under Evaluation for Delaying Cataract Progression
Josh Davidson, OD, FSLS, FAAOJosh Davidson, OD, FSLS, FAAO
